Curanex Pharmaceuticals Inc Common Stock (CURX) — Net Asset Quality Index
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Net Asset Quality Index of 98.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $14.48 Million minus total liabilities of $185.96K yields net assets of $14.29 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Curanex Pharmaceuticals Inc Common Stock asset portfolio for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Curanex Pharmaceuticals Inc Common Stock Net Asset Quality Index Over Time (2022–2024)
This chart shows how Curanex Pharmaceuticals Inc Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the index stands at 98.7%, representing net assets of $14.29 Million against total assets of $14.48 Million USD. See CURX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Curanex Pharmaceuticals Inc Common Stock (2022–2024)
The table below presents the year-by-year Net Asset Quality Index for Curanex Pharmaceuticals Inc Common Stock from 2022 to 2024, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Curanex Pharmaceuticals Inc Common Stock stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.2% | $503.36K | $517.93K | $14.57K | ▲ +16.4 pp |
| 2023 | 80.8% | $60.09K | $74.37K | $14.28K | ▼ -19.2 pp |
| 2022 | 100.0% | $10.23K | $10.23K | $0.00 | — |